The U.S. Congress is rising the question about the increasing cost of insulin. The U.S. congressmen believe that the high prices are connected to the failure of manufacturers. The insulin producers are ready to start the discussion but without the public notice. The first insulin injections have appeared on the U.S. market back in 1923. For the first time in more than 100 years, the U.S. government is incapable of controlling the insulin prices.
Statistically, the insulin price has risen by 50%. A bottle of Humalog was sold in 2001 for just $35, right now it costs over $275 for the same quantity. Some manufacturers start to produce much cheaper insulin with the price tag of less than $140 per every bottle. Canadian producers of insulin offer the treatment plans where one bottle costs from 2.28 to 6.35 U.S. dollars but the patient are still forced to overpay up to $400 per a monthly drug supply.
In January 2019, the US Democratic Party introduced a law aimed at reducing the cost of prescription drugs, while lawmakers sent a letter to 12 pharmaceutical companies, including Eli Lilly, Novo Nordisk and Sanofi.
Today, 3 companies dominate the production of insulin: Eli Lilly, Novo Nordisk and Sanofi – they control 90% of the market. Over the past two decades, Eli Lilly and Novo Nordisk have raised insulin prices by 450% due to the inflation. Such price rise turned out to be fatal for people from some of the ethnic groups with the highest rates of diabetes (coincidentally they are considered the poorest as well).
The high price forces diabetics to restrict the use of insulin, and this dangerous practice has caused a recent death series: the 22-year-old Antawi Lee Worsham (diabetes type 1) died of hypoglycaemia. Shane Patrick Boyle, the unemployed young man who cared for his sick mother, created a page on GoFundMe to buy his insulin and died when he was left to raise $50.
Over 7.4 million U.S. citizens have to find other sources of insulin while the congressmen decide on the price rise. Canadian pharmacies may offer cheaper solutions in short time.
According to Canadian researchers, the insulin price rise is less related to the transition to a more expensive analogue of insulin and to a greater degree of manufacturers’ initiative. This is confirmed by the dynamics of daily consumption of insulin during the period under investigation – the reduction is only by 3%.
Pharmacists explain the price rise for insulin by the need to compensate the discounts they provide to insurance companies so that they can cover the drug costs for U.S. citizens.
The rising cost of insulin sometimes made patients normalize drug consumption, despite the risk to health. The rise in prices has also repeatedly become a reason for holding protest rallies.
Canadian patients are also resorting to reduced intake of sugar suppressants and protest actions: despite the provision of these categories of citizens, obtaining preferential drugs is sometimes a problem.
That is why the use of Canadian Health&Care Mall can be a solution for diabetics. Right online drugstores in Canada such cheaper insulin-based meds for this category of patients –Humalog, NovoLog (NovoRapid), Lantus, Humulin, Victoza, Lucentis Vial 10mg/ml 0.23ml, Saxenda 6 mg/ml, Metformin 850mg. make sure to discuss the course of your personal diabetes treatment before trying a new medication.